ITCAPABILITIES · EVIDENCE TO ACTION
Innovation decisions that can survive real-world complexity.
ExaMedix works where emerging technology, operating constraints and important decisions intersect. We help frame the right problem, test the evidence and design focused initiatives before committing to large-scale implementation.
01 / DISCOVER
Innovation scouting & technology intelligence
Find credible signals across scientific research, digital health, applied AI, industry and emerging business models. The objective is not to produce a long trend list: it is to clarify which developments deserve attention now, later or not at all.
Signal to opportunity
Translate developments into specific operational questions, candidate use cases and stakeholder relevance.
Context before novelty
Look at adoption barriers, infrastructure, economics, regulation and timing before declaring an opportunity attractive.
02 / EVALUATE
Evidence and opportunity assessment
Technology claims are evaluated against available evidence, uncertainties, alternatives and the conditions required for practical value. An attractive demonstration is not, by itself, a business case.
Decision-oriented assessment
Structure the evidence, feasibility, material risks and assumptions that could change the decision.
Clear decision gates
Define what would justify stopping, investigating further, piloting or scaling.
03 / BUILD
Applied AI, research and strategic project design
ExaMedix explores AI-assisted analysis and computational methods where they may help investigate complex healthcare, scientific and operational problems. Research results are distinguished from validated products and clinical recommendations.
Focused project design
Specify scope, success measures, resource needs, risks, dependencies and milestones.
Pilot and validation paths
Run appropriately bounded experiments, document reproducibility and measure what was learned.
WHO WE WORK WITH
For organizations facing decisions, not just technologies
Relevant conversations include Swiss SMEs, healthcare organizations, technology companies, research collaborators and leaders evaluating an emerging opportunity. Engagements are defined around a practical question and a clear deliverable, not an indiscriminate catalogue of consulting services.
Start with a defined decision
What should the organization do, and what evidence is missing?
Leave with an actionable next step
A reasoned recommendation with explicit uncertainties, constraints and evaluation criteria.
Next conversation